• レポートコード:QFJ1-4681 • 出版社/出版日:QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、100ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、インプラント周囲炎の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(外科的、非外科的)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。 ・市場概要 ・インプラント周囲炎の市場動向 ・企業の競争状況、市場シェア ・インプラント周囲炎の種類別市場規模と予測2016-2027(外科的、非外科的) ・インプラント周囲炎の用途別市場規模と予測2016-2027(病院、クリニック、その他) ・インプラント周囲炎の北米市場規模2016-2027(アメリカ、カナダ) ・インプラント周囲炎の欧州市場規模2016-2027(ドイツ、フランス、イギリス等) ・インプラント周囲炎のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・インプラント周囲炎の中南米市場規模2016-2027(メキシコ、ブラジル) ・インプラント周囲炎の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Pfizer Inc.、Cadila Pharmaceuticals、R.N. Laboratories Pvt. Ltd.、Basic Pharma Life Science Pvt. Ltd.、Prachi Pharmaceuticals Private Limited.、Geistlich Pharma Inc.、Healthy Life Pharma) ・結論 |
Peri-implantitis is a destructive inflammatory process affecting the soft and hard tissues surrounding dental implants. The soft tissues become inflamed whereas the alveolar bone (hard tissue), which surrounds the implant for the purposes of retention, is lost over time.
Market Analysis and Insights: Global Peri-implantitis Market
The global Peri-implantitis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peri-implantitis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peri-implantitis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peri-implantitis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peri-implantitis market.
Global Peri-implantitis Scope and Market Size
Peri-implantitis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Peri-implantitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Surgical
Non-surgical
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer Inc.
Cadila Pharmaceuticals
R.N. Laboratories Pvt. Ltd.
Basic Pharma Life Science Pvt. Ltd.
Prachi Pharmaceuticals Private Limited.
Geistlich Pharma Inc.
Healthy Life Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peri-implantitis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgical
1.2.3 Non-surgical
1.3 Market by Application
1.3.1 Global Peri-implantitis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peri-implantitis Market Perspective (2016-2027)
2.2 Peri-implantitis Growth Trends by Regions
2.2.1 Peri-implantitis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peri-implantitis Historic Market Share by Regions (2016-2021)
2.2.3 Peri-implantitis Forecasted Market Size by Regions (2022-2027)
2.3 Peri-implantitis Industry Dynamic
2.3.1 Peri-implantitis Market Trends
2.3.2 Peri-implantitis Market Drivers
2.3.3 Peri-implantitis Market Challenges
2.3.4 Peri-implantitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peri-implantitis Players by Revenue
3.1.1 Global Top Peri-implantitis Players by Revenue (2016-2021)
3.1.2 Global Peri-implantitis Revenue Market Share by Players (2016-2021)
3.2 Global Peri-implantitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peri-implantitis Revenue
3.4 Global Peri-implantitis Market Concentration Ratio
3.4.1 Global Peri-implantitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peri-implantitis Revenue in 2020
3.5 Peri-implantitis Key Players Head office and Area Served
3.6 Key Players Peri-implantitis Product Solution and Service
3.7 Date of Enter into Peri-implantitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peri-implantitis Breakdown Data by Type
4.1 Global Peri-implantitis Historic Market Size by Type (2016-2021)
4.2 Global Peri-implantitis Forecasted Market Size by Type (2022-2027)
5 Peri-implantitis Breakdown Data by Application
5.1 Global Peri-implantitis Historic Market Size by Application (2016-2021)
5.2 Global Peri-implantitis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Peri-implantitis Market Size (2016-2027)
6.2 North America Peri-implantitis Market Size by Type
6.2.1 North America Peri-implantitis Market Size by Type (2016-2021)
6.2.2 North America Peri-implantitis Market Size by Type (2022-2027)
6.2.3 North America Peri-implantitis Market Size by Type (2016-2027)
6.3 North America Peri-implantitis Market Size by Application
6.3.1 North America Peri-implantitis Market Size by Application (2016-2021)
6.3.2 North America Peri-implantitis Market Size by Application (2022-2027)
6.3.3 North America Peri-implantitis Market Size by Application (2016-2027)
6.4 North America Peri-implantitis Market Size by Country
6.4.1 North America Peri-implantitis Market Size by Country (2016-2021)
6.4.2 North America Peri-implantitis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Peri-implantitis Market Size (2016-2027)
7.2 Europe Peri-implantitis Market Size by Type
7.2.1 Europe Peri-implantitis Market Size by Type (2016-2021)
7.2.2 Europe Peri-implantitis Market Size by Type (2022-2027)
7.2.3 Europe Peri-implantitis Market Size by Type (2016-2027)
7.3 Europe Peri-implantitis Market Size by Application
7.3.1 Europe Peri-implantitis Market Size by Application (2016-2021)
7.3.2 Europe Peri-implantitis Market Size by Application (2022-2027)
7.3.3 Europe Peri-implantitis Market Size by Application (2016-2027)
7.4 Europe Peri-implantitis Market Size by Country
7.4.1 Europe Peri-implantitis Market Size by Country (2016-2021)
7.4.2 Europe Peri-implantitis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Peri-implantitis Market Size (2016-2027)
8.2 Asia-Pacific Peri-implantitis Market Size by Type
8.2.1 Asia-Pacific Peri-implantitis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peri-implantitis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peri-implantitis Market Size by Type (2016-2027)
8.3 Asia-Pacific Peri-implantitis Market Size by Application
8.3.1 Asia-Pacific Peri-implantitis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peri-implantitis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peri-implantitis Market Size by Application (2016-2027)
8.4 Asia-Pacific Peri-implantitis Market Size by Region
8.4.1 Asia-Pacific Peri-implantitis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peri-implantitis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peri-implantitis Market Size (2016-2027)
9.2 Latin America Peri-implantitis Market Size by Type
9.2.1 Latin America Peri-implantitis Market Size by Type (2016-2021)
9.2.2 Latin America Peri-implantitis Market Size by Type (2022-2027)
9.2.3 Latin America Peri-implantitis Market Size by Type (2016-2027)
9.3 Latin America Peri-implantitis Market Size by Application
9.3.1 Latin America Peri-implantitis Market Size by Application (2016-2021)
9.3.2 Latin America Peri-implantitis Market Size by Application (2022-2027)
9.3.3 Latin America Peri-implantitis Market Size by Application (2016-2027)
9.4 Latin America Peri-implantitis Market Size by Country
9.4.1 Latin America Peri-implantitis Market Size by Country (2016-2021)
9.4.2 Latin America Peri-implantitis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peri-implantitis Market Size (2016-2027)
10.2 Middle East & Africa Peri-implantitis Market Size by Type
10.2.1 Middle East & Africa Peri-implantitis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peri-implantitis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peri-implantitis Market Size by Type (2016-2027)
10.3 Middle East & Africa Peri-implantitis Market Size by Application
10.3.1 Middle East & Africa Peri-implantitis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peri-implantitis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peri-implantitis Market Size by Application (2016-2027)
10.4 Middle East & Africa Peri-implantitis Market Size by Country
10.4.1 Middle East & Africa Peri-implantitis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peri-implantitis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Peri-implantitis Introduction
11.1.4 Pfizer Inc. Revenue in Peri-implantitis Business (2016-2021)
11.1.5 Pfizer Inc. Recent Development
11.2 Cadila Pharmaceuticals
11.2.1 Cadila Pharmaceuticals Company Details
11.2.2 Cadila Pharmaceuticals Business Overview
11.2.3 Cadila Pharmaceuticals Peri-implantitis Introduction
11.2.4 Cadila Pharmaceuticals Revenue in Peri-implantitis Business (2016-2021)
11.2.5 Cadila Pharmaceuticals Recent Development
11.3 R.N. Laboratories Pvt. Ltd.
11.3.1 R.N. Laboratories Pvt. Ltd. Company Details
11.3.2 R.N. Laboratories Pvt. Ltd. Business Overview
11.3.3 R.N. Laboratories Pvt. Ltd. Peri-implantitis Introduction
11.3.4 R.N. Laboratories Pvt. Ltd. Revenue in Peri-implantitis Business (2016-2021)
11.3.5 R.N. Laboratories Pvt. Ltd. Recent Development
11.4 Basic Pharma Life Science Pvt. Ltd.
11.4.1 Basic Pharma Life Science Pvt. Ltd. Company Details
11.4.2 Basic Pharma Life Science Pvt. Ltd. Business Overview
11.4.3 Basic Pharma Life Science Pvt. Ltd. Peri-implantitis Introduction
11.4.4 Basic Pharma Life Science Pvt. Ltd. Revenue in Peri-implantitis Business (2016-2021)
11.4.5 Basic Pharma Life Science Pvt. Ltd. Recent Development
11.5 Prachi Pharmaceuticals Private Limited.
11.5.1 Prachi Pharmaceuticals Private Limited. Company Details
11.5.2 Prachi Pharmaceuticals Private Limited. Business Overview
11.5.3 Prachi Pharmaceuticals Private Limited. Peri-implantitis Introduction
11.5.4 Prachi Pharmaceuticals Private Limited. Revenue in Peri-implantitis Business (2016-2021)
11.5.5 Prachi Pharmaceuticals Private Limited. Recent Development
11.6 Geistlich Pharma Inc.
11.6.1 Geistlich Pharma Inc. Company Details
11.6.2 Geistlich Pharma Inc. Business Overview
11.6.3 Geistlich Pharma Inc. Peri-implantitis Introduction
11.6.4 Geistlich Pharma Inc. Revenue in Peri-implantitis Business (2016-2021)
11.6.5 Geistlich Pharma Inc. Recent Development
11.7 Healthy Life Pharma
11.7.1 Healthy Life Pharma Company Details
11.7.2 Healthy Life Pharma Business Overview
11.7.3 Healthy Life Pharma Peri-implantitis Introduction
11.7.4 Healthy Life Pharma Revenue in Peri-implantitis Business (2016-2021)
11.7.5 Healthy Life Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Peri-implantitis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgical
Table 3. Key Players of Non-surgical
Table 4. Global Peri-implantitis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Peri-implantitis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Peri-implantitis Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Peri-implantitis Market Share by Regions (2016-2021)
Table 8. Global Peri-implantitis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Peri-implantitis Market Share by Regions (2022-2027)
Table 10. Peri-implantitis Market Trends
Table 11. Peri-implantitis Market Drivers
Table 12. Peri-implantitis Market Challenges
Table 13. Peri-implantitis Market Restraints
Table 14. Global Peri-implantitis Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Peri-implantitis Market Share by Players (2016-2021)
Table 16. Global Top Peri-implantitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peri-implantitis as of 2020)
Table 17. Ranking of Global Top Peri-implantitis Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Peri-implantitis Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Peri-implantitis Product Solution and Service
Table 21. Date of Enter into Peri-implantitis Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peri-implantitis Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Peri-implantitis Revenue Market Share by Type (2016-2021)
Table 25. Global Peri-implantitis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Peri-implantitis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Peri-implantitis Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Peri-implantitis Revenue Market Share by Application (2016-2021)
Table 29. Global Peri-implantitis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Peri-implantitis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Peri-implantitis Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Peri-implantitis Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Peri-implantitis Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Peri-implantitis Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Peri-implantitis Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Peri-implantitis Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Peri-implantitis Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Peri-implantitis Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Peri-implantitis Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Peri-implantitis Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Peri-implantitis Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Peri-implantitis Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Peri-implantitis Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Peri-implantitis Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Peri-implantitis Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Peri-implantitis Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Peri-implantitis Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Peri-implantitis Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Peri-implantitis Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Peri-implantitis Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Peri-implantitis Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Peri-implantitis Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Peri-implantitis Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Peri-implantitis Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Peri-implantitis Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Peri-implantitis Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Peri-implantitis Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Peri-implantitis Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Peri-implantitis Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Peri-implantitis Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Inc. Company Details
Table 62. Pfizer Inc. Business Overview
Table 63. Pfizer Inc. Peri-implantitis Product
Table 64. Pfizer Inc. Revenue in Peri-implantitis Business (2016-2021) & (US$ Million)
Table 65. Pfizer Inc. Recent Development
Table 66. Cadila Pharmaceuticals Company Details
Table 67. Cadila Pharmaceuticals Business Overview
Table 68. Cadila Pharmaceuticals Peri-implantitis Product
Table 69. Cadila Pharmaceuticals Revenue in Peri-implantitis Business (2016-2021) & (US$ Million)
Table 70. Cadila Pharmaceuticals Recent Development
Table 71. R.N. Laboratories Pvt. Ltd. Company Details
Table 72. R.N. Laboratories Pvt. Ltd. Business Overview
Table 73. R.N. Laboratories Pvt. Ltd. Peri-implantitis Product
Table 74. R.N. Laboratories Pvt. Ltd. Revenue in Peri-implantitis Business (2016-2021) & (US$ Million)
Table 75. R.N. Laboratories Pvt. Ltd. Recent Development
Table 76. Basic Pharma Life Science Pvt. Ltd. Company Details
Table 77. Basic Pharma Life Science Pvt. Ltd. Business Overview
Table 78. Basic Pharma Life Science Pvt. Ltd. Peri-implantitis Product
Table 79. Basic Pharma Life Science Pvt. Ltd. Revenue in Peri-implantitis Business (2016-2021) & (US$ Million)
Table 80. Basic Pharma Life Science Pvt. Ltd. Recent Development
Table 81. Prachi Pharmaceuticals Private Limited. Company Details
Table 82. Prachi Pharmaceuticals Private Limited. Business Overview
Table 83. Prachi Pharmaceuticals Private Limited. Peri-implantitis Product
Table 84. Prachi Pharmaceuticals Private Limited. Revenue in Peri-implantitis Business (2016-2021) & (US$ Million)
Table 85. Prachi Pharmaceuticals Private Limited. Recent Development
Table 86. Geistlich Pharma Inc. Company Details
Table 87. Geistlich Pharma Inc. Business Overview
Table 88. Geistlich Pharma Inc. Peri-implantitis Product
Table 89. Geistlich Pharma Inc. Revenue in Peri-implantitis Business (2016-2021) & (US$ Million)
Table 90. Geistlich Pharma Inc. Recent Development
Table 91. Healthy Life Pharma Company Details
Table 92. Healthy Life Pharma Business Overview
Table 93. Healthy Life Pharma Peri-implantitis Product
Table 94. Healthy Life Pharma Revenue in Peri-implantitis Business (2016-2021) & (US$ Million)
Table 95. Healthy Life Pharma Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peri-implantitis Market Share by Type: 2020 VS 2027
Figure 2. Surgical Features
Figure 3. Non-surgical Features
Figure 4. Global Peri-implantitis Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Peri-implantitis Report Years Considered
Figure 9. Global Peri-implantitis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Peri-implantitis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Peri-implantitis Market Share by Regions: 2020 VS 2027
Figure 12. Global Peri-implantitis Market Share by Regions (2022-2027)
Figure 13. Global Peri-implantitis Market Share by Players in 2020
Figure 14. Global Top Peri-implantitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peri-implantitis as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Peri-implantitis Revenue in 2020
Figure 16. Global Peri-implantitis Revenue Market Share by Type (2016-2021)
Figure 17. Global Peri-implantitis Revenue Market Share by Type (2022-2027)
Figure 18. North America Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Peri-implantitis Market Share by Type (2016-2027)
Figure 20. North America Peri-implantitis Market Share by Application (2016-2027)
Figure 21. North America Peri-implantitis Market Share by Country (2016-2027)
Figure 22. United States Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Peri-implantitis Market Share by Type (2016-2027)
Figure 26. Europe Peri-implantitis Market Share by Application (2016-2027)
Figure 27. Europe Peri-implantitis Market Share by Country (2016-2027)
Figure 28. Germany Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Peri-implantitis Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Peri-implantitis Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Peri-implantitis Market Share by Region (2016-2027)
Figure 38. China Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Peri-implantitis Market Share by Type (2016-2027)
Figure 46. Latin America Peri-implantitis Market Share by Application (2016-2027)
Figure 47. Latin America Peri-implantitis Market Share by Country (2016-2027)
Figure 48. Mexico Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Peri-implantitis Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Peri-implantitis Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Peri-implantitis Market Share by Country (2016-2027)
Figure 54. Turkey Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Peri-implantitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Inc. Revenue Growth Rate in Peri-implantitis Business (2016-2021)
Figure 58. Cadila Pharmaceuticals Revenue Growth Rate in Peri-implantitis Business (2016-2021)
Figure 59. R.N. Laboratories Pvt. Ltd. Revenue Growth Rate in Peri-implantitis Business (2016-2021)
Figure 60. Basic Pharma Life Science Pvt. Ltd. Revenue Growth Rate in Peri-implantitis Business (2016-2021)
Figure 61. Prachi Pharmaceuticals Private Limited. Revenue Growth Rate in Peri-implantitis Business (2016-2021)
Figure 62. Geistlich Pharma Inc. Revenue Growth Rate in Peri-implantitis Business (2016-2021)
Figure 63. Healthy Life Pharma Revenue Growth Rate in Peri-implantitis Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed